-64.9%
SNDU vs GSK
-10.1%
-54.9%
-96.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -31.6% | -0.1% | -31.5% | -31.8% |
| 7D | -51.0% | -5.3% | -45.7% | -56.0% |
| 30D | -83.3% | -3.7% | -79.6% | -84.0% |
| 3M | -88.8% | -7.3% | -81.6% | -89.8% |
| 6M | -91.5% | -4.2% | -87.2% | -91.4% |
| All | -64.9% | -10.1% | -54.9% | -62.3% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling